ストックスクリーナーアプリを入手
3.46
2.81%
-0.10
アフターアワーズ：
3.46
前日終値:
$3.56
開ける：
$3.56
24時間の取引高:
40,313
Relative Volume:
0.17
時価総額：
$82.86M
収益：
$48.20M
当期純損益:
$-35.05M
株価収益率:
-2.2076
EPS:
-1.5673
ネットキャッシュフロー:
$-13.02M
1週間 パフォーマンス:
+6.46%
1か月 パフォーマンス:
+54.46%
6か月 パフォーマンス:
+61.68%
1年 パフォーマンス:
+20.98%
1日の値動き範囲:
$3.2435
$3.62
1週間の範囲:
$3.03
$3.6399
52週間の値動き範囲:
$1.06
$5.22
Celularity Inc Stock (CELU) Company Profile
CELU を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CELU
Celularity Inc
|
3.46 | 85.26M | 48.20M | -35.05M | -13.02M | -1.5673 |
|
VRTX
Vertex Pharmaceuticals Inc
|
390.30 | 101.51B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
565.97 | 59.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.73 | 56.69B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
652.43 | 39.57B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
309.69 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Celularity Inc Stock (CELU) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-01-30 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2022-12-22 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-06-22 | 開始されました | H.C. Wainwright | Buy |
| 2022-04-06 | ダウングレード | Truist | Buy → Hold |
| 2022-01-28 | 開始されました | Oppenheimer | Outperform |
| 2021-11-24 | 開始されました | Morgan Stanley | Equal-Weight |
すべてを表示
Celularity Inc (CELU) 最新ニュース
Momentum Indicator Shows Bearish Divergence in Celularity Inc. Equity Warrant - 선데이타임즈
Celularity Inc. (NASDAQ:CELU) Held Back By Insufficient Growth Even After Shares Climb 59% - simplywall.st
Celularity Enters Series Seed Stock Agreement with Defeye Amid Compliance Issues - AInvest
Published on: 2025-08-14 01:07:04 - 선데이타임즈
Celularity Enters Series Seed Stock Agreement with Defeye - TipRanks
Published on: 2025-08-04 10:28:51 - beatles.ru
What is Celularity Inc. Equity Warrant company’s growth strategyBuild wealth steadily with expert advice - Jammu Links News
What is the risk reward ratio of investing in Celularity Inc. Equity Warrant stockFree Predictions - Jammu Links News
Is Celularity Inc. Equity Warrant stock overvalued or undervaluedFree Capital Allocation Plans - Jammu Links News
How does Celularity Inc. Equity Warrant generate profit in a changing economyBreakout portfolio performance - Jammu Links News
How does Celularity Inc. generate profit in a changing economyAchieve superior capital gains with smart trades - Jammu Links News
When is Celularity Inc. stock expected to show significant growthMaximize returns with expert trading insights - Jammu Links News
Does Celularity Inc. Equity Warrant stock perform well during market downturnsBuild a diversified portfolio for sustainable growth - Jammu Links News
What institutional investors are buying Celularity Inc. stockIdentify breakout stocks before they peak - Jammu Links News
What is Celularity Inc. company’s growth strategySuperior returns - Jammu Links News
Is Celularity Inc. a good long term investmentCapitalize on market momentum for big wins - Jammu Links News
Is it the right time to buy Celularity Inc. Equity Warrant stockInvest smarter with daily stock recommendations - Jammu Links News
How many analysts rate Celularity Inc. as a “Buy”Explosive earning power - Jammu Links News
What are analysts’ price targets for Celularity Inc. Equity Warrant in the next 12 monthsMaximize returns with strategic stock selection - Jammu Links News
What analysts say about Celularity Inc. stockBuild wealth steadily with smart stock selection - Jammu Links News
Does Celularity Inc. stock perform well during market downturnsOutstanding yields - Jammu Links News
What analysts say about Celularity Inc. Equity Warrant stockMaximize returns with disciplined trading approaches - Jammu Links News
What drives Celularity Inc. stock priceIdentify undervalued stocks ready to soar - Jammu Links News
What are analysts’ price targets for Celularity Inc. in the next 12 monthsExceptional ROI - Jammu Links News
How strong is Celularity Inc. company’s balance sheetDouble or triple returns - Jammu Links News
Is Celularity Inc. a growth stock or a value stockInvest like a pro with expert recommendations - Jammu Links News
When is Celularity Inc. Equity Warrant stock expected to show significant growthAchieve impressive returns with smart timing - Jammu Links News
How does Celularity Inc. Equity Warrant compare to its industry peersStock Strategy Trend Scanner For Every Investor - Jammu Links News
Is it the right time to buy Celularity Inc. stockSwing Trade Entry Points For Fast Growth - Jammu Links News
Short Term Charts Align With Long Term Uptrend in Celularity Inc.Swing Setup With Technical Confirmation Explained - metal.it
Live Scanner Shows Breakout on Celularity Inc.Trade With Low Risk Exposure - beatles.ru
Celularity Inc. Equity Warrant Breaks Below Key Support LevelStep-by-Step Stock Investment Guide Gains Popularity - metal.it
Celularity Issues $6.8M Promissory Note and 3.7M Warrant for $2.528/Share - AInvest
What is the dividend policy of Celularity Inc. stockAdvanced Screener Guidance From AI Tools - Jammu Links News
Celularity Issues Promissory Note and Warrant - TipRanks
Celularity Secures $2M Through Private Placement Deal - The Globe and Mail
What catalysts could drive Celularity Inc. stock higher in 2025Expert Picks Signals To Watch Now - Jammu Links News
What are Celularity Inc. Equity Warrant company’s key revenue driversRetirement Planning Target Finder Backed By Experts - Jammu Links News
Celularity Secures $2M via Private Placement Deal - AInvest
What is the risk reward ratio of investing in Celularity Inc. stockBeginner Investor Review Backed By Experts - Jammu Links News
Celularity Inc. Equity Warrant stock trend forecastFundamental + Technical Hybrid Stock Tips Shared - metal.it
Celularity (CELU) raises $2M via private placement, issues warrants | PDS SEC FilingForm 6-K - Stock Titan
Relative strength of Celularity Inc. Equity Warrant in sector analysisLow Risk Buy Zone Opportunity Watch Ongoing - metal.it
Technical Charts Suggest Momentum Shift in Celularity Inc.Market Entry and Exit Point Tips From Traders - metal.it
What makes Celularity Inc. stock price move sharplyWeekly Stock Watch With Growth Focus Expanded - metal.it
Intrinsic Value of Celularity Inc. Stock: Is It Undervalued or OvervaluedTriple Digit Return Stock Predictions Released - metal.it
Options Data Show Bullish Bias in Celularity Inc.Risk Adjusted Technical Entry Plan Gains Followers - metal.it
Why Celularity Inc. Equity Warrant stock attracts strong analyst attentionAI Driven Stock Trend Forecast Shows Momentum Shift - metal.it
Celularity Inc. Equity Warrant At Decision Level — Rebound or ResistanceChart Breakout Buy Signal Detection Confirmed - metal.it
What are the latest earnings results for Celularity Inc.Outstanding yields - Jammu Links News
Celularity Inc. Ranks High in Smart Money TrackerSmart Investment Tips Gaining Popularity Among Analysts - metal.it
Celularity Inc (CELU) 財務データ
収益
当期純利益
現金流量
EPS
Celularity Inc (CELU) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Hariri Robert J | Chief Executive Officer |
Apr 13 '25 |
Option Exercise |
0.00 |
3,281 |
0 |
21,482 |
| Haines John R | Senior Exec Vice President |
Apr 13 '25 |
Option Exercise |
0.00 |
1,641 |
0 |
29,698 |
| Beers David C | Chief Financial Officer |
Apr 13 '25 |
Option Exercise |
0.00 |
1,025 |
0 |
18,561 |
| Brigido Stephen | Pres., Functional Regeneration |
Feb 17 '25 |
Option Exercise |
0.00 |
10,000 |
0 |
11,641 |
| Beers David C | Chief Financial Officer |
Feb 17 '25 |
Option Exercise |
0.00 |
12,500 |
0 |
21,932 |
| Haines John R | Senior Exec Vice President |
Feb 17 '25 |
Option Exercise |
0.00 |
20,000 |
0 |
35,092 |
0.11%
1.56%
大文字化:
|
ボリューム (24 時間):